Fetal Growth Restriction a Case Control Study

Maternal Serum Progesterone And Placental Heme Oxgenase-1 Expression In Early Onset Idiopathic Fetal Growth Restriction: A Case Control Study

The study aims to investigate the responsible factors that leads to idiopathic fetal growth restriction.

The study aims to investigate the relationship between maternal serum level of progesterone, immune-expression of HMOX-1 a placental angiogenesis marker with idiopathic fetal growth restriction.

Inclusion Criteria:

• singleton
• dated pregnancy

Exclusion Criteria:

• fetus with structural or chromosomal anomaly
• receive treatments such as aspirin, progestogen, low molecular weight heparin
• has pre-existing medical disorders such as autoimmune disease, hypertension, diabetes
• smoking
• suspected intrauterine infection